BLCO Strangle Strategy
BLCO (Bausch + Lomb Corporation), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
BLCO (Bausch + Lomb Corporation) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $5.79B, a beta of 0.59 versus the broader market, a 52-week range of 10.99-18.915, average daily share volume of 461K, a public-listing history dating back to 2022, approximately 14K full-time employees. These structural characteristics shape how BLCO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.59 indicates BLCO has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on BLCO?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current BLCO snapshot
As of May 15, 2026, spot at $16.07, ATM IV 18.10%, IV rank 0.65%, expected move 5.19%. The strangle on BLCO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on BLCO specifically: BLCO IV at 18.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a BLCO strangle, with a market-implied 1-standard-deviation move of approximately 5.19% (roughly $0.83 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BLCO expiries trade a higher absolute premium for lower per-day decay. Position sizing on BLCO should anchor to the underlying notional of $16.07 per share and to the trader's directional view on BLCO stock.
BLCO strangle setup
The BLCO strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BLCO near $16.07, the first option leg uses a $16.87 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BLCO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BLCO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $16.87 | N/A |
| Buy 1 | Put | $15.27 | N/A |
BLCO strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
BLCO strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on BLCO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on BLCO
Strangles on BLCO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the BLCO chain.
BLCO thesis for this strangle
The market-implied 1-standard-deviation range for BLCO extends from approximately $15.24 on the downside to $16.90 on the upside. A BLCO long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current BLCO IV rank near 0.65% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BLCO at 18.10%. As a Healthcare name, BLCO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BLCO-specific events.
BLCO strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BLCO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BLCO alongside the broader basket even when BLCO-specific fundamentals are unchanged. Always rebuild the position from current BLCO chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on BLCO?
- A strangle on BLCO is the strangle strategy applied to BLCO (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With BLCO stock trading near $16.07, the strikes shown on this page are snapped to the nearest listed BLCO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BLCO strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the BLCO strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 18.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BLCO strangle?
- The breakeven for the BLCO strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BLCO market-implied 1-standard-deviation expected move is approximately 5.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on BLCO?
- Strangles on BLCO are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the BLCO chain.
- How does current BLCO implied volatility affect this strangle?
- BLCO ATM IV is at 18.10% with IV rank near 0.65%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.